Baker Tilly Wealth Management, LLC Aspira Women'S Health Inc. Transaction History

Baker Tilly Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$0.32 - $0.58 $14,346 - $26,003	44,834 Added 150.82%	74,560 $27,000
Q4 2022 Jan 26, 2023	SELL	$0.3 - $0.41 $387 - $529	-1,292 Reduced 4.17%	29,726 $0
Q3 2022 Oct 20, 2022	SELL	$0.38 - $1.07 $622 - $1,753	-1,639 Reduced 5.02%	31,018 $12,000
Q2 2022 Jul 28, 2022	SELL	$0.4 - $1.09 $1,685 - $4,592	-4,213 Reduced 11.43%	32,657 $19,000
Q1 2022 Apr 27, 2022	BUY	$0.88 - $1.81 $13,416 - $27,595	15,246 Added 70.5%	36,870 $38,000
Q4 2021 Feb 08, 2022	SELL	$1.63 - $3.43 $932 - $1,961	-572 Reduced 2.58%	21,624 $38,000
Q3 2021 Nov 02, 2021	BUY	$3.19 - $5.48 $70,805 - $121,634	22,196 New	22,196 $72,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.